epidermal growth factor

(redirected from EGF)
Also found in: Dictionary, Thesaurus, Medical, Legal, Financial, Acronyms, Wikipedia.

epidermal growth factor

[‚ep·ə¦dərm·əl ′grōth ‚fak·tər]
(physiology)
A polypeptide produced in animals that stimulates and sustains the replication of epidermal cells (of ectodermal or endodermal origin); its human equivalent is urogastrone.
References in periodicals archive ?
The amounts of mucin in the cells of methylprotodioscin-treated cultures were 100 [+ or -] 4%, 273 [+ or -] 2%, 312 [+ or -] 13%, 252 [+ or -] 31% and 105 [+ or -] 12% for control, 25 ng/ml of EGF alone, EGF plus methylprotodioscin [10.
Toxin A titres showed significant reduction in animals receiving EGF after antibiotic pretreatment when compared to group 5.
conformational change of EGFr that is necessary to shape the EGF binding
Boasting staggering results, BIOEFFECT EGF SERUM contains EGF (Epidermal Growth Factor), a cellular activator that improves the appearance and health of your skin by encouraging the skin to repair its own cells.
The festivities after the event at the Els Club last weekend were rounded off by the EGF presenting the Order of Merit awards for the 2009-10 season.
EGF will identify an equal number of male and female primary school students to participate in the program.
pivotal trial assessing the efficacy and safety of its EGF receptor monoclonal
Yet the article states that "if normal cell growth runs amok, the [normal] EGF receptor follows its cell-division signals with a self-destruct message.
The findings suggest that patients with reflux laryngitis lack a certain amount of protective effect that saliva normally provides to the digestive tract via elements like EGF and bicarbonate.
It consists of a humanized monoclonal antibody tyrosie kinase inhibitor based on EGF (epidermal growth factor) to help prevent metastases for brain and neck cancers, in conjunction with radiotherapy.
Methods are provided for inhibiting the differentiation of adipocyte precursor cells, and for treating or preventing obesity, which comprise administering an effective amount of a composition capable of binding to and activating the EGF receptor, preferably epidermal EGF or a functional derivative thereof, TGF Alpha , an antibody specific for the EGF receptor or an anti-idiotypic antibody specific for an idiotope on an antibody specific for EGF.